A low-cost, paper-based hybrid capture assay to detect high-risk HPV DNA for cervical cancer screening in low-resource settings

• DOI: 10.1039/d2lc00885h
• Publication Date: 2022-12-22T16:41:10Z
• Authors: Chelsey A. Smith; Megan M. Chang; Kathryn A. Kundrod; Emilie N. Novak; Sonia G. Parra; Leticia López; Celda Mavume; Cesaltina Lorenzoni; Mauricio Maza; Mila P. Salcedo; Jennifer L. Carns; Ellen Baker; Jane Montealegre; Michael Scheurer; Philip E. Castle; Kathleen M. Schmeler; Rebecca R. Richar...
• Keywords: Papillomavirus Infections; Uterine Cervical Neoplasms; DNA; 3. Good health; Chemistry; User-Computer Interface; 03 medical and health sciences; 0302 clinical medicine; Humans; Female; Papillomaviridae; Early Detection of Cancer

A low-cost, user friendly 2DPN for cervical cancer screening was developed and validated for detection of high-risk HPV DNA in clinical samples.